Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline and Celecoxib in Bipolar Depression
NCT02703363Phase 3Completed
- Sponsor
- Pakistan Institute of Living and Learning
- Start
- Aug 2016
- Primary completion
- Dec 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of minocycline, celecoxib in bipolar disorder (BD), sponsored by Pakistan Institute of Living and Learning. Started Aug 2016; status: completed.
02
Drugs
minocyclinecelecoxib
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT02703363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02703363.